Cannabidiol (CBD) is now associated with reducing methamphetamine cravings in rats, according to data published in the Journal of Psychopharmacology.
Researchers in Australia studied the impact of CBD on methamphetamine-seeking behavior, reported NORML. They found that CBD dosing reduced the rats’ motivation to self-administer methamphetamine. It also reduced the likelihood of relapse following drug abstinence.
“This is the first demonstration that cannabidiol can reduce the motivation to seek and consume methamphetamine, and suggests that cannabidiol might be worth trialing as a novel pharmacotherapy for methamphetamine dependence,” the researchers stated.
Prior studies have found that CBD can reduce cravings for tobacco, heroin, cocaine, and opioids.